Cite

HARVARD Citation

    Spiera, R. et al. (n.d.). OP0126 A phase 2 study of safety and efficacy of anabasum (JBT-101) in systemic sclerosis. Annals of the rheumatic diseases. p. 105. [Online]. 
  
Back to record